Rush University Medical Center

 

Rush University Medical Center
T

The Impact of Hormonal Therapies for Breast and Prostate Cancers on the CV System: Endocrine Therapy, ADT, Outcome Data, Risk Factors

By Rush University Medical Center FEATURING Tochukwu Okwuosa
By Rush University Medical Center FEATURING Tochukwu Okwuosa
79 views
June 14, 2021
0 Comments
Login to view comments. Click here to Login
Videos
05:12
Rush University Medical Center

Current Unmet Needs and Challenges in 1L Treatment Approaches for EG…

Feat. M. Fidler
10:22
Rush University Medical Center

Clinical Implications of CheckMate 9ER Data: Applications for Practi…

Feat. A. Tan
06:50
Rush University Medical Center

Post-Operative Therapy in NSCLC

Feat. M. Fidler
09:39
Rush University Medical Center

The Impact of Hormonal Therapies for Breast and Prostate Cancers on …

Feat. T. Okwuosa
05:28
Rush University Medical Center

HER2CLIMB Data on TKIs for HER2+ MBC: How Effective Is Tucatinib? Wh…

Feat. R. Rao
12:54
Rush University Medical Center

2020 Update on EGFR+ mNSCLC: How Effective Is the Addition of Newly …

Feat. M. Fidler
32:28
Rush University Medical Center

Rush Cancer Care During COVID-19: Have Outpatient Visits Decreased? …

Feat. M. Levy
34:24
Rush University Medical Center

Managing COVID-19 at Rush Medical Center: In Which Situations Would …

Feat. M. Yoder
11:22
Rush University Medical Center

COVID-19, CV Risk Factors and Racial Differences in Mortality: What …

Feat. K. Williams
12:56
Rush University Medical Center

COVID-19 & African Americans: How Can We Recalibrate What's…

Feat. C. Yancy
07:00
Rush University Medical Center

COVID-19: Treatment with ACE Inhibitors and Angiotensin Receptor Blo…

Feat. A. Santos Volgman
13:25
Rush University Medical Center

What Are the Consequences of the COVID-19 Pandemic on Interventional…

Feat. C. Kavinsky
19:49
Rush University Medical Center

COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Feat. S. Jain